XT
DARE icon

XTX Topco’s Dare Bioscience DARE Stock Holding History

XTX Topco’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,339
Closed -$40.7K – 4237
2026
Q1 		$40.7K Buy
22,339
+11,356
+103% +$19.4K ﹤0.01% 3376
2025
Q4 		$21.2K Buy
+10,983
New +$21.9K ﹤0.01% 3049
2024
Q2 		– Sell
-2,341
Closed -$13.8K – 1984
2024
Q1 		$13.8K Buy
+2,341
New +$11.5K ﹤0.01% 1647
2022
Q3 		– Sell
-1,571
Closed -$23K – 1152
2022
Q2 		$23K Sell
1,571
-582
-27% -$8.76K 0.01% 803
2022
Q1 		$38K Buy
2,153
+429
+25% +$8.11K 0.02% 611
2021
Q4 		$41K Sell
1,724
-842
-33% -$17.3K 0.02% 583
2021
Q3 		$51K Buy
2,566
+1,391
+118% +$27.4K 0.02% 602
2021
Q2 		$27K Buy
+1,175
New +$20.1K 0.01% 755

Other funds holding DARE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

XTX Topco's DARE Position: Q2 2026 in Review

XTX Topco sold out of Dare Bioscience (DARE) in Q2 2026, closing a stake of 22,339 shares — an estimated $40.7K sold.

XTX Topco first reported a position in DARE in Q2 2021 and held it in 8 quarters. The position peaked at $51K in Q3 2021. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • XTX Topco reported no remaining Dare Bioscience position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 22,339 Dare Bioscience shares in Q2 2026, an estimated $40.7K.
  • XTX Topco first reported a position in Dare Bioscience in Q2 2021 and held it in 8 quarters.
  • XTX Topco's Dare Bioscience position peaked at $51K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.